---
schema_version: "secwatch.filing_event.v1"
accession: "0001140361-24-001339"
form_type: "8-K"
ticker: "SSKN"
cik: "0001051514"
company_name: "STRATA Skin Sciences, Inc."
filed_at: "2024-01-08T23:59:59+00:00"
generated_at: "2026-06-07T01:56:04.102063+00:00"
event_type: "other"
sentiment: "positive"
materiality_score: 0.25
calibrated_materiality_score: 0.25
confidence: "medium"
source: SEC EDGAR
---

# STRATA Skin Sciences presents TheraClear®X acne study at Maui Derm 2024

## Summary
- Poster reports one treatment session using TheraClear®X with needle insert for cystic and papular acne.
- Majority of lesions achieved ≥50% clearing by 1-2 weeks; average reduction score 3.5 (50-75% reduction).
- Most frequent adverse event was mild hyperpigmentation; erythema, edema, flaking seen in ≤10% of lesions.
- Conference takes place Jan 22-26, 2024 at Grand Wailea in Maui, Hawaii.

## SEC filing metadata
- accession: 0001140361-24-001339
- form_type: 8-K
- ticker: SSKN
- cik: 0001051514
- company_name: STRATA Skin Sciences, Inc.
- filed_at: 2024-01-08T23:59:59+00:00
- event_type: other
- sentiment: positive
- materiality_score: 0.25
- calibrated_materiality_score: 0.25
- confidence: medium
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1051514/000114036124001339/0001140361-24-001339-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1051514/000114036124001339/ef20018284_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001140361-24-001339
- JSON: https://secwatch.observer/filing/0001140361-24-001339.json
- Plain text: https://secwatch.observer/filing/0001140361-24-001339.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.